Read our latest news and insights to keep on top of the latest trends and regulatory changes around the world.
CUHK study has been featured in DAILY MAIL UK, "Can looking in the loo help your health... or is it just potty? Scientists say checking before flushing can provide vital clues to your wellbeing.
GenieBiome appoints Mr. Alan Chow as CFO.
GenieBiome collaborates with CUHK on clinical trial to study the impact of a microbiome immunity formula SIM02 in the reduction of vaccine-related adverse reaction and improvement of COVID-19 vaccine efficacy.
CUHK study shows modulation of gut microbiota helps enhance safety and efficacy of COVID-19 vaccine.
CUHK study has been featured in FOX NEWS, "Intestinal bacteria may affect severity of coronavirus, researchers find."
CUHK study has been featured in DECCAN HERALD, "Imbalance in gut bacteria linked to 'long Covid' infection risk, says study.
CUHK developed the first rationally designed microbial formula clinically proven to hasten recovery.
Diagnosis and treatment protocol for COVID-19 from the National Health Commission of China includes the use of probiotics.
Admission into the
HKSTP-KINGMED CO-INCUBATION SCHEME
CUHK scientists develop a probiotic formula to modulate gut dysbiosis in COVID-19.